Bio-Techne Introduces Streamlined Brand Architecture to Help Customers Navigate Solutions Faster and With Greater Clarity
Bio-Techne to Host Conference Call on May 6, 2026, to Announce Third Quarter Fiscal 2026 Financial Results
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories
Bio-Techne's Ella Platform Achieves CE-IVD Marking Expanding Access to Rapid, Cartridge?Based Immunoassays for European Clinical Laboratories
Bio-Techne Expands 3D Stem Cell and Organoid Culture Portfolio with a Fully Defined Synthetic Alternative
Bio-Techne?Launches Simple?Plex?Ultra-Sensitive?Assays on Ella?Platform to Enable?Femtogram-Level?Detection of Neurological Biomarkers
Bio-Techne to Host Conference Call on February 4, 2026, to Announce Second Quarter Fiscal 2026 Financial Results
Oreterra Ready to Drill at Trek South Copper-Gold Prospect, Golden Triangle, BC - Contractors in Place for Maiden Program
Standard Uranium Intersects Anomalous Radioactivity and Graphitic Reactivated Structure at Rocas Uranium Project; Initial Drill Program Complete
QIMC Intersects 243 m Natural Hydrogen Zone Including 163 m Continuous Elevated Interval at West Advocate - Strongest Response to Date
